Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Covaxin: Phase 3 Trial Data Shared With Expert Panel
Description
In March Bharat Biotech released a "first interim analysis" of Phase III trial results, and said it demonstrated 81 per cent interim efficacy in preventing COVID-19.
More from User
01:24
Business tycoon Pallonji Mistry, who headed Shapoorji Pallonji Group, dies
NYOOOZ TV
01:10
‘Leaving Germany after a productive visit’: PM Modi leaves for UAE
NYOOOZ TV
01:07
Mumbai: Building collapse in Kurla leaves 2 dead, 11 injured
NYOOOZ TV
01:27
Assam floods: Toll rises to 127, over 22 lakh people still affected
NYOOOZ TV
01:15
Kriti Sanon posts video of the workouts she hates on Instagram, watch
NYOOOZ TV
01:33
Aww! Neetu Kapoor’s emotional reaction as paps say ‘Junior Kapoor on the way’
NYOOOZ TV
Related Videos
02:02
Bharat biotech submits phase 3 trial data, expert panel meet today| Covaxin | Oneindia News
Oneindia
01:49
Covaxin Phase 3 Trial Data: DCGI’s Expert Panel Says Bharat Biotech’s Vaccine 77.8% Effective
LatestLY
02:30
Bharat Biotech submits Covaxin Phase 3 trial data, expert panel meet today
India Today
01:36
Bharat Biotech's Covaxin Recommended By Expert Panel For Phase II III Trials On 2-18 Year-Olds
Odisha TV
01:08
We are Excited to Share insights from a data management Industry Expert Mohammad AI-Sogour Executive VP of Shared Services.
srikanth banchode
12:38
Panel recommends phase 2/3 trials of Covaxin on children
Aaj Tak